{
  "success": true,
  "pagesUsed": [
    2,
    6,
    8,
    9,
    13,
    14,
    20,
    28
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "Synopsis",
        "text": "Synopsis",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "Synopsis",
        "sectionType": {
          "id": "47828d87-857e-4393-b775-f630de7ba75e",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "Schedule of Activities",
        "text": "Schedule of Activities",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "Schedule of Activities",
        "sectionType": {
          "id": "c0f58a7c-da31-4255-bc04-3cec9441454c",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_3",
        "name": "Introduction",
        "text": "Introduction",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "Introduction",
        "sectionType": {
          "id": "6bb9558e-6d81-4c99-bac4-fa0420dbab7e",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2",
          "nci_3_3"
        ]
      },
      {
        "id": "nc_4",
        "name": "Objectives and Endpoints",
        "text": "Objectives and Endpoints",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "Objectives and Endpoints",
        "sectionType": {
          "id": "f82acb02-0270-4c3f-aec3-6c7dbf42ebd7",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_5",
        "name": "Study Design",
        "text": "Study Design",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "Study Design",
        "sectionType": {
          "id": "ac568712-7c61-4133-93c0-a56d9b58c76f",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4",
          "nci_5_5"
        ]
      },
      {
        "id": "nc_6",
        "name": "Study Population",
        "text": "Study Population",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "Study Population",
        "sectionType": {
          "id": "a3bfafd4-a4a4-41c4-b806-f5f6725a9b01",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1",
          "nci_6_2",
          "nci_6_3",
          "nci_6_4"
        ]
      },
      {
        "id": "nc_7",
        "name": "Treatments",
        "text": "Treatments",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "7",
        "sectionTitle": "Treatments",
        "sectionType": {
          "id": "92b955c8-adac-4139-bd0f-eeb8d0f350bc",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_7_1",
          "nci_7_2",
          "nci_7_3",
          "nci_7_4",
          "nci_7_5",
          "nci_7_6",
          "nci_7_7",
          "nci_7_8",
          "nci_7_9",
          "nci_7_10"
        ]
      },
      {
        "id": "nc_8",
        "name": "Abbreviations and Definitions",
        "text": "Abbreviations and Definitions",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 1",
        "sectionTitle": "Abbreviations and Definitions",
        "sectionType": {
          "id": "84dc4012-b07d-4252-ae83-d28f7942b658",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_9",
        "name": "Clinical Laboratory Tests",
        "text": "Clinical Laboratory Tests",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 2",
        "sectionTitle": "Clinical Laboratory Tests",
        "sectionType": {
          "id": "598fce0f-a1cd-402a-8527-ec3d4687b809",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "Study Governance Considerations",
        "text": "Study Governance Considerations",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 3",
        "sectionTitle": "Study Governance Considerations",
        "sectionType": {
          "id": "15fbf8af-c073-447d-b74c-a53d7ce5589e",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_11",
        "name": "Hepatic Monitoring Tests for Treatment-Emergent Abnormality",
        "text": "Hepatic Monitoring Tests for Treatment-Emergent Abnormality",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 4",
        "sectionTitle": "Hepatic Monitoring Tests for Treatment-Emergent Abnormality",
        "sectionType": {
          "id": "1b759cc5-2c1a-472e-bd33-6e1393daba56",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_12",
        "name": "World Health Organization Classification of Diabetes and Diagnostic Criteria",
        "text": "World Health Organization Classification of Diabetes and Diagnostic Criteria",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 5",
        "sectionTitle": "World Health Organization Classification of Diabetes and Diagnostic Criteria",
        "sectionType": {
          "id": "93ca97b2-54f0-4014-be59-28e37843951a",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_13",
        "name": "Classification of Contraceptive Methods",
        "text": "Classification of Contraceptive Methods",
        "order": 12,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 6",
        "sectionTitle": "Classification of Contraceptive Methods",
        "sectionType": {
          "id": "1a60709c-8370-4db6-89b2-f5697c5c7fb4",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_14",
        "name": "Management of Patients with Severe, Persistent Hyperglycemia during the Treatment Period",
        "text": "Management of Patients with Severe, Persistent Hyperglycemia during the Treatment Period",
        "order": 13,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 7",
        "sectionTitle": "Management of Patients with Severe, Persistent Hyperglycemia during the Treatment Period",
        "sectionType": {
          "id": "9376eb1b-7caa-40cd-ad67-b75408a8e1d6",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_15",
        "name": "Changes to Study Procedures due to the COVID-19 Pandemic",
        "text": "Changes to Study Procedures due to the COVID-19 Pandemic",
        "order": 14,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 8",
        "sectionTitle": "Changes to Study Procedures due to the COVID-19 Pandemic",
        "sectionType": {
          "id": "62c15c83-8f28-443f-85c1-4c5f074e65f8",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_16",
        "name": "Protocol Amendment I8F-MC-GPGM(b)",
        "text": "Protocol Amendment I8F-MC-GPGM(b)",
        "order": 15,
        "instanceType": "NarrativeContent",
        "sectionNumber": "Appendix 9",
        "sectionTitle": "Protocol Amendment I8F-MC-GPGM(b)",
        "sectionType": {
          "id": "df53986d-f496-4c5d-8bb7-7eef4a5b3794",
          "code": "Appendix",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Appendix",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_3_1",
        "name": "Study Rationale",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Study Rationale"
      },
      {
        "id": "nci_3_2",
        "name": "Background",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_3_3",
        "name": "Benefit/Risk Assessment",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Benefit/Risk Assessment"
      },
      {
        "id": "nci_5_1",
        "name": "Overall Design",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Overall Design"
      },
      {
        "id": "nci_5_2",
        "name": "Number of Participants",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Number of Participants"
      },
      {
        "id": "nci_5_3",
        "name": "End of Study Definition",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "End of Study Definition"
      },
      {
        "id": "nci_5_4",
        "name": "Scientific Rationale for Study Design",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.4",
        "sectionTitle": "Scientific Rationale for Study Design"
      },
      {
        "id": "nci_5_5",
        "name": "Justification for Dose",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.5",
        "sectionTitle": "Justification for Dose"
      },
      {
        "id": "nci_6_1",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_6_2",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_6_3",
        "name": "Lifestyle Restrictions",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.3",
        "sectionTitle": "Lifestyle Restrictions"
      },
      {
        "id": "nci_6_4",
        "name": "Screen Failures",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.4",
        "sectionTitle": "Screen Failures"
      },
      {
        "id": "nci_7_1",
        "name": "Treatments Administered",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.1",
        "sectionTitle": "Treatments Administered"
      },
      {
        "id": "nci_7_2",
        "name": "Packaging and Labeling",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.1.1",
        "sectionTitle": "Packaging and Labeling"
      },
      {
        "id": "nci_7_3",
        "name": "Medical Devices",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.1.2",
        "sectionTitle": "Medical Devices"
      },
      {
        "id": "nci_7_4",
        "name": "Method of Treatment Assignment",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2",
        "sectionTitle": "Method of Treatment Assignment"
      },
      {
        "id": "nci_7_5",
        "name": "Selection and Timing of Doses",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2.1",
        "sectionTitle": "Selection and Timing of Doses"
      },
      {
        "id": "nci_7_6",
        "name": "LY3298176",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2.1.1",
        "sectionTitle": "LY3298176"
      },
      {
        "id": "nci_7_7",
        "name": "Insulin Glargine",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.2.1.2",
        "sectionTitle": "Insulin Glargine"
      },
      {
        "id": "nci_7_8",
        "name": "Blinding",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.3",
        "sectionTitle": "Blinding"
      },
      {
        "id": "nci_7_9",
        "name": "Dosage Modification",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.4",
        "sectionTitle": "Dosage Modification"
      },
      {
        "id": "nci_7_10",
        "name": "Study Drugs",
        "text": "",
        "order": 9,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.4.1",
        "sectionTitle": "Study Drugs"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "T2DM",
        "expandedText": "type 2 diabetes mellitus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "GIP",
        "expandedText": "glucose-dependent insulinotropic polypeptide",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "GLP-1",
        "expandedText": "glucagon-like peptide-1",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "QW",
        "expandedText": "once weekly",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "CV",
        "expandedText": "cardiovascular",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "HbA1c",
        "expandedText": "hemoglobin A1c",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "SARS-CoV-2",
        "expandedText": "severe acute respiratory syndrome coronavirus 2",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "COVID-19",
        "expandedText": "Coronavirus Disease 2019",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "ADA",
        "expandedText": "anti-drug antibodies",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "APPADL",
        "expandedText": "Ability to Perform Physical Activities of Daily Living",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "BG",
        "expandedText": "blood glucose",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "BP",
        "expandedText": "blood pressure",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "CKD-EPI",
        "expandedText": "Chronic Kidney Disease-Epidemiology",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "DTSQc",
        "expandedText": "Diabetes Treatment Satisfaction Questionnaire change",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "DTSQs",
        "expandedText": "Diabetes Treatment Satisfaction Questionnaire status",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "ECG",
        "expandedText": "electrocardiogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "eGFR",
        "expandedText": "estimated glomerular filtration rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "EQ-5D-5L",
        "expandedText": "European Qualtiy of Life-dimensions",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "ET",
        "expandedText": "early termination",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "FTV",
        "expandedText": "final treatment visit",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "F/U",
        "expandedText": "follow-up",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "GAD",
        "expandedText": "glutamic acid decarboxylase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "HR",
        "expandedText": "heart rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "IW-SP",
        "expandedText": "Impact of Weight on Self Perception",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "LY",
        "expandedText": "LY3298176",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "PK",
        "expandedText": "pharmacokinetics",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "PRO",
        "expandedText": "patient-reported outcome",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "SGLT-2i",
        "expandedText": "sodium-glucose co-transporter-2 inhibitor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "SMBG",
        "expandedText": "self-monitored blood glucose",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "SU",
        "expandedText": "sulfonylurea",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "TTT",
        "expandedText": "treat-to-target",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "Tx",
        "expandedText": "treatment",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "QD",
        "expandedText": "once daily",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 16,
      "itemCount": 22,
      "abbreviationCount": 33
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "Efficacy and Safety of LY3298176 Once Weekly versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "I8F-MC-GPGM(b)",
      "versionDate": "Not explicitly provided in text",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12",
        "nc_13",
        "nc_14",
        "nc_15",
        "nc_16"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "T2DM",
          "expansion": "type 2 diabetes mellitus"
        },
        {
          "abbreviation": "GIP",
          "expansion": "glucose-dependent insulinotropic polypeptide"
        },
        {
          "abbreviation": "GLP-1",
          "expansion": "glucagon-like peptide-1"
        },
        {
          "abbreviation": "QW",
          "expansion": "once weekly"
        },
        {
          "abbreviation": "CV",
          "expansion": "cardiovascular"
        },
        {
          "abbreviation": "HbA1c",
          "expansion": "hemoglobin A1c"
        },
        {
          "abbreviation": "SARS-CoV-2",
          "expansion": "severe acute respiratory syndrome coronavirus 2"
        },
        {
          "abbreviation": "COVID-19",
          "expansion": "Coronavirus Disease 2019"
        },
        {
          "abbreviation": "ADA",
          "expansion": "anti-drug antibodies"
        },
        {
          "abbreviation": "APPADL",
          "expansion": "Ability to Perform Physical Activities of Daily Living"
        },
        {
          "abbreviation": "BG",
          "expansion": "blood glucose"
        },
        {
          "abbreviation": "BP",
          "expansion": "blood pressure"
        },
        {
          "abbreviation": "CKD-EPI",
          "expansion": "Chronic Kidney Disease-Epidemiology"
        },
        {
          "abbreviation": "DTSQc",
          "expansion": "Diabetes Treatment Satisfaction Questionnaire change"
        },
        {
          "abbreviation": "DTSQs",
          "expansion": "Diabetes Treatment Satisfaction Questionnaire status"
        },
        {
          "abbreviation": "ECG",
          "expansion": "electrocardiogram"
        },
        {
          "abbreviation": "eGFR",
          "expansion": "estimated glomerular filtration rate"
        },
        {
          "abbreviation": "EQ-5D-5L",
          "expansion": "European Qualtiy of Life-dimensions"
        },
        {
          "abbreviation": "ET",
          "expansion": "early termination"
        },
        {
          "abbreviation": "FTV",
          "expansion": "final treatment visit"
        },
        {
          "abbreviation": "F/U",
          "expansion": "follow-up"
        },
        {
          "abbreviation": "GAD",
          "expansion": "glutamic acid decarboxylase"
        },
        {
          "abbreviation": "HR",
          "expansion": "heart rate"
        },
        {
          "abbreviation": "IW-SP",
          "expansion": "Impact of Weight on Self Perception"
        },
        {
          "abbreviation": "LY",
          "expansion": "LY3298176"
        },
        {
          "abbreviation": "PK",
          "expansion": "pharmacokinetics"
        },
        {
          "abbreviation": "PRO",
          "expansion": "patient-reported outcome"
        },
        {
          "abbreviation": "SGLT-2i",
          "expansion": "sodium-glucose co-transporter-2 inhibitor"
        },
        {
          "abbreviation": "SMBG",
          "expansion": "self-monitored blood glucose"
        },
        {
          "abbreviation": "SU",
          "expansion": "sulfonylurea"
        },
        {
          "abbreviation": "TTT",
          "expansion": "treat-to-target"
        },
        {
          "abbreviation": "Tx",
          "expansion": "treatment"
        },
        {
          "abbreviation": "QD",
          "expansion": "once daily"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "Efficacy and Safety of LY3298176 Once Weekly versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)",
        "version": "I8F-MC-GPGM(b)",
        "versionDate": "Not explicitly provided in text"
      },
      "sections": [
        {
          "number": "1",
          "title": "Synopsis",
          "type": "Synopsis"
        },
        {
          "number": "2",
          "title": "Schedule of Activities",
          "type": "Study Procedures"
        },
        {
          "number": "3",
          "title": "Introduction",
          "type": "Introduction",
          "subsections": [
            {
              "number": "3.1",
              "title": "Study Rationale"
            },
            {
              "number": "3.2",
              "title": "Background"
            },
            {
              "number": "3.3",
              "title": "Benefit/Risk Assessment"
            }
          ]
        },
        {
          "number": "4",
          "title": "Objectives and Endpoints",
          "type": "Objectives"
        },
        {
          "number": "5",
          "title": "Study Design",
          "type": "Study Design",
          "subsections": [
            {
              "number": "5.1",
              "title": "Overall Design"
            },
            {
              "number": "5.2",
              "title": "Number of Participants"
            },
            {
              "number": "5.3",
              "title": "End of Study Definition"
            },
            {
              "number": "5.4",
              "title": "Scientific Rationale for Study Design"
            },
            {
              "number": "5.5",
              "title": "Justification for Dose"
            }
          ]
        },
        {
          "number": "6",
          "title": "Study Population",
          "type": "Study Population",
          "subsections": [
            {
              "number": "6.1",
              "title": "Inclusion Criteria"
            },
            {
              "number": "6.2",
              "title": "Exclusion Criteria"
            },
            {
              "number": "6.3",
              "title": "Lifestyle Restrictions"
            },
            {
              "number": "6.4",
              "title": "Screen Failures"
            }
          ]
        },
        {
          "number": "7",
          "title": "Treatments",
          "type": "Treatment",
          "subsections": [
            {
              "number": "7.1",
              "title": "Treatments Administered"
            },
            {
              "number": "7.1.1",
              "title": "Packaging and Labeling"
            },
            {
              "number": "7.1.2",
              "title": "Medical Devices"
            },
            {
              "number": "7.2",
              "title": "Method of Treatment Assignment"
            },
            {
              "number": "7.2.1",
              "title": "Selection and Timing of Doses"
            },
            {
              "number": "7.2.1.1",
              "title": "LY3298176"
            },
            {
              "number": "7.2.1.2",
              "title": "Insulin Glargine"
            },
            {
              "number": "7.3",
              "title": "Blinding"
            },
            {
              "number": "7.4",
              "title": "Dosage Modification"
            },
            {
              "number": "7.4.1",
              "title": "Study Drugs"
            }
          ]
        },
        {
          "number": "Appendix 1",
          "title": "Abbreviations and Definitions",
          "type": "Appendix"
        },
        {
          "number": "Appendix 2",
          "title": "Clinical Laboratory Tests",
          "type": "Appendix"
        },
        {
          "number": "Appendix 3",
          "title": "Study Governance Considerations",
          "type": "Appendix"
        },
        {
          "number": "Appendix 4",
          "title": "Hepatic Monitoring Tests for Treatment-Emergent Abnormality",
          "type": "Appendix"
        },
        {
          "number": "Appendix 5",
          "title": "World Health Organization Classification of Diabetes and Diagnostic Criteria",
          "type": "Appendix"
        },
        {
          "number": "Appendix 6",
          "title": "Classification of Contraceptive Methods",
          "type": "Appendix"
        },
        {
          "number": "Appendix 7",
          "title": "Management of Patients with Severe, Persistent Hyperglycemia during the Treatment Period",
          "type": "Appendix"
        },
        {
          "number": "Appendix 8",
          "title": "Changes to Study Procedures due to the COVID-19 Pandemic",
          "type": "Appendix"
        },
        {
          "number": "Appendix 9",
          "title": "Protocol Amendment I8F-MC-GPGM(b)",
          "type": "Appendix"
        }
      ]
    }
  }
}